Edouard Moinet

Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France.

Cathay Innovation SAS is a venture capital firm, a subsidiary of Cathay Capital Private Equity SAS founded in 2015 by Denis Barrier and Ming Po Cai. Cathay Innovation SAS is headquartered in Paris.

Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year.

CCIF Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 12, 2021 and is headquartered in New York, NY.

Seaowl France SASU specializes in the maritime and coastal freight transport. The company was founded in 2008 and is headquartered in Levallois-Perret, France.

NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA.

Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The company is based in Rueil-Malmaison, France.

Part of SOPHiA GENETICS SA, SOPHiA GENETICS SAS provides data processing, hosting and related activity services. The company is based in Montpellier, France.

L Catterton Europe SASU is a Private Equity firm, a subsidiary of Catterton Management Co. LLC founded in 1989 by Philippe Franchet. L Catterton Europe SASU is headquartered in Paris.

Innis & Gunn Holdings Ltd. is a holding British company that produces and sells beer. The private company is based in Edinburgh, UK. and has subsidiaries in United Kingdom and Canada. The company was founded in 2007.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

Fondations Capital France SASU is an Independent Private Equity firm founded in 2003. Fondations Capital France SASU is headquartered in Paris.

Part of Somfy SA, Domis SA is a French company that manufactures alarm systems. The company is based in Rumilly, France. Marc Westermann has been the CEO of the company since 2019.

Myfox, Inc. provides consumer electronics. The firm specializes in smart home, connected home, smart home security system and connected home innovator. The company was founded by Jean-Marc Prunet and is headquartered in Campbell, CA.

Somfy Protect by Myfox SAS develops and manufactures security systems. It designs and produces connected, sensor-driven and wireless home security equipment. The company was founded by Jean Prunet in 2005 and is headquartered in Labege, France.

Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals.

Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies.

Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France.

Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.

Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands.

TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel.

LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France.

Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA.

Dermala, Inc. develops treatments for the chronic skin diseases. It focuses on the most prevalent skin diseases like acne and eczema and skin conditions like skin aging. The firm is developing end-to-end solutions that will consist of microbiome analysis, personalized topical and oral treatments and an app for tracking the treatment outcome and treatment optimization via data analytics, machine learning and AI. The company was founded by Lada Rasochova in 2014 and is headquartered in San Diego, CA.

Ganymed Robotics SAS develops robots for orthopaedic surgeries. The company was founded by Sophie Cahen in June 26, 2018 and is headquartered in Paris, France.

Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France.

Part of Pierre Fabre Participations SAS, Pierre Fabre Ltd. is a British company that develops innovative solutions for the well-being of everyone, from health to beauty. The company is based in London, UK. The company's flagship products include purifying mist, fortifying shampoo, dry shampoo, and anti-dandruff shampoo for hair care, as well as treatments for chronic diseases such as heavy legs, urinary disorders, allergies, type 2 diabetes, and anemia. The company also offers a range of iconic brands under the Pierre Fabre brand, including Eau Thermale Avène, Ducray, Dexeryl, Eludril, Elgydium, and Naturactive. The company has a best practices guide for relations with patient associations to ensure responsible and sound decision-making.